Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:06
04/13/21
04/13
12:06
04/13/21
12:06
JNJ

Johnson & Johnson

$157.65 /

-3.935 (-2.44%)

, MRNA

Moderna

$149.34 /

+10.05 (+7.22%)

, GRAB

Grab

/

+

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, BA

Boeing

$251.46 /

+1.8 (+0.72%)

, AGC

Altimeter Growth

$13.46 /

-0.46 (-3.30%)

, NVCR

Novocure

$185.99 /

+54.38 (+41.32%)

, CDLX

Cardlytics

$102.70 /

-9.03 (-8.08%)

, AHCO

AdaptHealth

$31.35 /

-5.7 (-15.38%)

, BALY

Bally's

$54.81 /

-5.99 (-9.85%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

The major averages are…

ShowHide Related Items >><<
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
GRAB Grab
/

+

COIN Coinbase
$0.00 /

+ (+0.00%)

04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
BA Boeing
$251.46 /

+1.8 (+0.72%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

NVCR Novocure
$185.99 /

+54.38 (+41.32%)

04/13/21 Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
04/13/21 Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

04/13/21 Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
04/13/21 Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
04/12/21 Baird
AdaptHealth price target raised to $49 from $47 at Baird
03/18/21 Truist
AdaptHealth initiated with a Buy at Truist amid home health market shift
BALY Bally's
$54.81 /

-5.99 (-9.85%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

  • 14
    Apr
  • 16
    Apr
  • 03
    Mar
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

On The Fly
Fly Intel: Pre-market Movers » 08:58
04/13/21
04/13
08:58
04/13/21
08:58
AGC

Altimeter Growth

$13.94 /

+0.21 (+1.53%)

, NVCR

Novocure

$131.91 /

-0.1 (-0.08%)

, CDLX

Cardlytics

$111.96 /

+0.81 (+0.73%)

, MRNA

Moderna

$139.36 /

-1.52 (-1.08%)

, MFNC

Mackinac Financial

$13.26 /

-0.23 (-1.70%)

, FAST

Fastenal

$50.73 /

+0.7 (+1.40%)

, ATXI

Avenue Therapeutics

$7.11 /

+0.215 (+3.12%)

, BALY

Bally's

$60.79 /

-0.885 (-1.43%)

, AAL

American Airlines

$22.92 /

-0.625 (-2.66%)

, JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

Check out this morning's…

ShowHide Related Items >><<
NVCR Novocure
$131.91 /

-0.1 (-0.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

ATXI Avenue Therapeutics
$7.11 /

+0.215 (+3.12%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

NVCR Novocure
$131.91 /

-0.1 (-0.08%)

03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
02/25/21 Piper Sandler
'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler
01/29/21 Truist
Novocure price target raised to $132 from $118 at Truist
01/25/21 Piper Sandler
Novocure price target raised to $225 from $140 at Piper Sandler
CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

01/21/21 Baird
Fastenal should be bought on any weakness, says Baird
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/16/20 Deutsche Bank
Fastenal downgraded to Hold from Buy at Deutsche Bank
10/15/20 Stephens
Fastenal resumed with an Overweight at Stephens
ATXI Avenue Therapeutics
$7.11 /

+0.215 (+3.12%)

03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
BALY Bally's
$60.79 /

-0.885 (-1.43%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
AAL American Airlines
$22.92 /

-0.625 (-2.66%)

04/06/21 Morgan Stanley
American Airlines initiated with an Underweight at Morgan Stanley
03/30/21
Fly Intel: Top five analyst upgrades
03/30/21 Jefferies
Jefferies upgrades American Airlines to Hold on outperformance potential
03/30/21 Citi
Citi takes 'cautious view' on American Airlines capacity additions
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
NVCR Novocure
$131.91 /

-0.1 (-0.08%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

  • 16
    Apr
  • 03
    Mar
  • 10
    Nov
  • 23
    Jun
  • 19
    May
MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

MFNC Mackinac Financial
$13.26 /

-0.23 (-1.70%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

FAST Fastenal
$50.73 /

+0.7 (+1.40%)

BALY Bally's
$60.79 /

-0.885 (-1.43%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

MRNA Moderna
$139.36 /

-1.52 (-1.08%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

AGC Altimeter Growth
$13.94 /

+0.21 (+1.53%)

AAL American Airlines
$22.92 /

-0.625 (-2.66%)

Hot Stocks
Cardlytics to acquire Bridg for $350M in cash » 06:40
04/13/21
04/13
06:40
04/13/21
06:40
CDLX

Cardlytics

$111.96 /

+0.81 (+0.73%)

Cardlytics announced its…

Cardlytics announced its intent to acquire Bridg, a customer data platform that empowers marketers to better understand and reach customers using SKU-level insights. Once the integration is complete, this addition will pair Cardlytics' advertising platform, which has an audience of more than 163M monthly active users, with Bridg's enhanced SKU-level insights and ability to engage consumers across other digital platforms. Subject to closing conditions, Cardlytics has agreed to acquire Bridg for approximately $350M in cash at closing. In addition, Cardlytics has agreed to make two potential earnout payments in cash and stock on the first and second anniversary of the closing based on Bridg's U.S. annualized revenue run rate. Cardlytics expects these payments could equal approximately $100M-$300M in the aggregate.

ShowHide Related Items >><<
CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
CDLX Cardlytics
$111.96 /

+0.81 (+0.73%)

  • 03
    Mar
Over a week ago
Recommendations
Cardlytics price target raised to $130 from $110 at JPMorgan » 05:05
03/16/21
03/16
05:05
03/16/21
05:05
CDLX

Cardlytics

$132.34 /

+0.2 (+0.15%)

JPMorgan analyst Doug…

JPMorgan analyst Doug Anmuth raised the firm's price target on Cardlytics to $130 from $110 and keeps a Neutral rating on the shares. The analyst is "incrementally positive" on Cardlytics saying it is executing well on its strategic initiatives. The U.S. business is already back to pre-pandemic levels and the shares are down 16% from their all-time high on February 12, Anmuth tells investors in a research note. He believes the automated self-serve platform, new user experience, and Dosh acquisition could drive upside to estimates over time.

ShowHide Related Items >><<
CDLX Cardlytics
$132.34 /

+0.2 (+0.15%)

CDLX Cardlytics
$132.34 /

+0.2 (+0.15%)

03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
CDLX Cardlytics
$132.34 /

+0.2 (+0.15%)

  • 03
    Mar
Over a month ago
Conference/Events
Truist Securities to hold a virtual conference » 10:18
03/09/21
03/09
10:18
03/09/21
10:18
GOCO

GoHealth

$11.47 /

-0.39 (-3.29%)

, CLNY

Colony Capital

$6.32 /

+0.11 (+1.77%)

, BCO

Brink's

$82.15 /

+0.36 (+0.44%)

, DNB

Dun & Bradstreet

$22.88 /

+0.92 (+4.19%)

, CDLX

Cardlytics

$127.22 /

+5.59 (+4.60%)

, WK

Workiva

$99.80 /

+4.69 (+4.93%)

, BIGC

BigCommerce

$60.37 /

+4.03 (+7.15%)

, AFRM

Affirm

$79.50 /

+5.19 (+6.98%)

, CRTO

Criteo

$33.15 /

+1.15 (+3.59%)

, EXPO

Exponent

$96.20 /

+0.1 (+0.10%)

, RDFN

Redfin

$64.48 /

+5.3 (+8.96%)

, ZS

Zscaler

$180.42 /

+12.39 (+7.37%)

, EB

Eventbrite

$22.15 /

+0.605 (+2.81%)

, PD

PagerDuty

$36.69 /

+2.49 (+7.28%)

, CCOI

Cogent

$60.65 /

+0.5 (+0.83%)

, SPLK

Splunk

$136.31 /

+5.17 (+3.94%)

2021 Technology, Internet…

2021 Technology, Internet & Services Virtual Conference

ShowHide Related Items >><<
ZS Zscaler
$180.42 /

+12.39 (+7.37%)

WK Workiva
$99.80 /

+4.69 (+4.93%)

SPLK Splunk
$136.31 /

+5.17 (+3.94%)

RDFN Redfin
$64.48 /

+5.3 (+8.96%)

PD PagerDuty
$36.69 /

+2.49 (+7.28%)

GOCO GoHealth
$11.47 /

-0.39 (-3.29%)

EXPO Exponent
$96.20 /

+0.1 (+0.10%)

EB Eventbrite
$22.15 /

+0.605 (+2.81%)

DNB Dun & Bradstreet
$22.88 /

+0.92 (+4.19%)

CRTO Criteo
$33.15 /

+1.15 (+3.59%)

CLNY Colony Capital
$6.32 /

+0.11 (+1.77%)

CDLX Cardlytics
$127.22 /

+5.59 (+4.60%)

CCOI Cogent
$60.65 /

+0.5 (+0.83%)

BIGC BigCommerce
$60.37 /

+4.03 (+7.15%)

BCO Brink's
$82.15 /

+0.36 (+0.44%)

AFRM Affirm
$79.50 /

+5.19 (+6.98%)

GOCO GoHealth
$11.47 /

-0.39 (-3.29%)

11/12/20 Evercore ISI
GoHealth price target lowered to $25 from $27 at Evercore ISI
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/02/20 Raymond James
GoHealth initiated with an Outperform at Raymond James
08/14/20 Evercore ISI
GoHealth added to Tactical Outperform List at Evercore ISI
CLNY Colony Capital
$6.32 /

+0.11 (+1.77%)

03/09/21 B. Riley
Colony Capital price target raised to $8 from $6 at B. Riley Securities
02/22/21 Cowen
Colony Capital initiated with an Outperform at Cowen
12/08/20 B. Riley
Colony Capital price target raised to $6 from $5 at B. Riley Securities
12/03/20 Truist
Colony Capital initiated with a Buy at Truist
BCO Brink's
$82.15 /

+0.36 (+0.44%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 Goldman Sachs
Brink's reinstated with a Buy at Goldman Sachs
01/15/21 Truist
Brink's price target raised to $96 from $90 at Truist
12/15/20 Truist
Brink's price target raised to $90 from $80 at Truist
DNB Dun & Bradstreet
$22.88 /

+0.92 (+4.19%)

08/11/20 Truist
Black Knight price target raised to $93 from $81 at Truist
07/28/20 Citi
Dun & Bradstreet initiated with a Neutral at Citi
07/27/20 JPMorgan
Dun & Bradstreet initiated with a Neutral at JPMorgan
07/27/20 Wells Fargo
Dun & Bradstreet initiated with an Equal Weight at Wells Fargo
CDLX Cardlytics
$127.22 /

+5.59 (+4.60%)

03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
WK Workiva
$99.80 /

+4.69 (+4.93%)

02/18/21 Morgan Stanley
Workiva price target raised to $110 from $82 at Morgan Stanley
01/04/21 William Blair
Workiva initiated with an Outperform at William Blair
12/17/20
Fly Intel: Top five analyst upgrades
12/17/20 Morgan Stanley
Morgan Stanley upgrades Workiva to Equal Weight after 'very impressive' changes
BIGC BigCommerce
$60.37 /

+4.03 (+7.15%)

03/08/21 Piper Sandler
Piper Sandler 'aggressive' buyer of BigCommerce on recent pullback
02/24/21
Fly Intel: Top five analyst upgrades
02/24/21 KeyBanc
BigCommerce upgraded to Overweight at KeyBanc
02/24/21 KeyBanc
BigCommerce upgraded to Overweight from Sector Weight at KeyBanc
AFRM Affirm
$79.50 /

+5.19 (+6.98%)

02/16/21 Barclays
Affirm price target raised to $148 from $132 at Barclays
02/12/21 RBC Capital
Affirm price target raised to $155 from $130 at RBC Capital
02/12/21 Morgan Stanley
Affirm price target raised to $146 from $142 at Morgan Stanley
02/08/21
Fly Intel: Top five analyst initiations
CRTO Criteo
$33.15 /

+1.15 (+3.59%)

02/19/21 Berenberg
Criteo price target raised to $39.50 from $28.25 at Berenberg
02/12/21 Truist
Criteo price target raised to $37 from $20 at Truist
02/11/21 Macquarie
Criteo upgraded to Outperform from Neutral at Macquarie
02/11/21 Citi
Criteo price target raised to $32 from $20 at Citi
EXPO Exponent
$96.20 /

+0.1 (+0.10%)

01/20/21 Truist
Exponent price target raised to $105 from $81 at Truist
05/13/20 Sidoti
Exponent upgraded to Buy from Neutral at Sidoti
04/09/20 Sidoti
Exponent downgraded to Neutral from Buy at Sidoti
03/19/20 Sidoti
Exponent upgraded to Buy from Neutral at Sidoti
RDFN Redfin
$64.48 /

+5.3 (+8.96%)

02/25/21 DA Davidson
Redfin price target raised to $92 from $70 at DA Davidson
02/25/21 Piper Sandler
Redfin price target raised to $99 from $73 at Piper Sandler
02/23/21 Truist
Redfin price target raised to $102 from $84 at Truist
02/19/21 Piper Sandler
Redfin purchase of RentPath 'strategically compelling,' says Piper Sandler
ZS Zscaler
$180.42 /

+12.39 (+7.37%)

03/05/21 Berenberg
Zscaler upgraded to Buy from Hold at Berenberg
02/26/21 Loop Capital
Zscaler price target raised to $250 from $215 at Loop Capital
02/26/21 BTIG
Zscaler upgraded to Buy from Neutral at BTIG
02/26/21 Deutsche Bank
Zscaler price target raised to $233 from $225 at Deutsche Bank
EB Eventbrite
$22.15 /

+0.605 (+2.81%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 Truist
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 Truist
Eventbrite upgraded to Buy from Hold at SunTrust
PD PagerDuty
$36.69 /

+2.49 (+7.28%)

03/08/21 Credit Suisse
PagerDuty assumed at Neutral at Credit Suisse
01/26/21 Baird
PagerDuty price target raised to $53 from $43 at Baird
01/20/21 Berenberg
PagerDuty upgraded to Buy from Hold at Berenberg
01/04/21 Craig-Hallum
PagerDuty price target raised to $52 from $45 at Craig-Hallum
CCOI Cogent
$60.65 /

+0.5 (+0.83%)

02/03/21 MoffettNathanson
Cogent upgraded to Buy on reopening and recovery at MoffettNathanson
02/03/21 MoffettNathanson
Cogent upgraded to Buy from Neutral at MoffettNathanson
11/17/20 RBC Capital
Cogent price target lowered to $70 from $79 at RBC Capital
11/04/20 Citi
Cogent price target lowered to $75 from $89 at Citi
SPLK Splunk
$136.31 /

+5.17 (+3.94%)

03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
03/04/21 Goldman Sachs
Splunk price target lowered to $215 from $240 at Goldman Sachs
03/04/21 DA Davidson
Splunk price target lowered to $156 from $177 at DA Davidson
03/04/21 Barclays
Splunk price target lowered to $206 from $220 at Barclays
ZS Zscaler
$180.42 /

+12.39 (+7.37%)

WK Workiva
$99.80 /

+4.69 (+4.93%)

SPLK Splunk
$136.31 /

+5.17 (+3.94%)

RDFN Redfin
$64.48 /

+5.3 (+8.96%)

PD PagerDuty
$36.69 /

+2.49 (+7.28%)

GOCO GoHealth
$11.47 /

-0.39 (-3.29%)

EXPO Exponent
$96.20 /

+0.1 (+0.10%)

EB Eventbrite
$22.15 /

+0.605 (+2.81%)

DNB Dun & Bradstreet
$22.88 /

+0.92 (+4.19%)

CRTO Criteo
$33.15 /

+1.15 (+3.59%)

CLNY Colony Capital
$6.32 /

+0.11 (+1.77%)

CDLX Cardlytics
$127.22 /

+5.59 (+4.60%)

CCOI Cogent
$60.65 /

+0.5 (+0.83%)

BIGC BigCommerce
$60.37 /

+4.03 (+7.15%)

BCO Brink's
$82.15 /

+0.36 (+0.44%)

AFRM Affirm
$79.50 /

+5.19 (+6.98%)

  • 03
    Mar
  • 13
    Jan
  • 13
    Nov
  • 05
    Aug
  • 15
    Jul
  • 01
    Jul
SPLK Splunk
$136.31 /

+5.17 (+3.94%)

CRTO Criteo
$33.15 /

+1.15 (+3.59%)

CLNY Colony Capital
$6.32 /

+0.11 (+1.77%)

AFRM Affirm
$79.50 /

+5.19 (+6.98%)

ZS Zscaler
$180.42 /

+12.39 (+7.37%)

WK Workiva
$99.80 /

+4.69 (+4.93%)

SPLK Splunk
$136.31 /

+5.17 (+3.94%)

RDFN Redfin
$64.48 /

+5.3 (+8.96%)

PD PagerDuty
$36.69 /

+2.49 (+7.28%)

GOCO GoHealth
$11.47 /

-0.39 (-3.29%)

EXPO Exponent
$96.20 /

+0.1 (+0.10%)

EB Eventbrite
$22.15 /

+0.605 (+2.81%)

DNB Dun & Bradstreet
$22.88 /

+0.92 (+4.19%)

CRTO Criteo
$33.15 /

+1.15 (+3.59%)

CLNY Colony Capital
$6.32 /

+0.11 (+1.77%)

BIGC BigCommerce
$60.37 /

+4.03 (+7.15%)

AFRM Affirm
$79.50 /

+5.19 (+6.98%)

ZS Zscaler
$180.42 /

+12.39 (+7.37%)

SPLK Splunk
$136.31 /

+5.17 (+3.94%)

RDFN Redfin
$64.48 /

+5.3 (+8.96%)

PD PagerDuty
$36.69 /

+2.49 (+7.28%)

CRTO Criteo
$33.15 /

+1.15 (+3.59%)

BIGC BigCommerce
$60.37 /

+4.03 (+7.15%)

AFRM Affirm
$79.50 /

+5.19 (+6.98%)

Hot Stocks
Cardlytics completes acquisition of Dosh » 09:20
03/09/21
03/09
09:20
03/09/21
09:20
CDLX

Cardlytics

$121.03 /

-6.56 (-5.14%)

Cardlytics announced the…

Cardlytics announced the completion of its acquisition of Dosh, a cash-back offers platform. Previously announced on March 1, this acquisition will combine the scale of Cardlytics' advertising platform - with an audience of more than 163 million monthly active users - alongside Dosh's innovation, giving advertisers the ability to engage with consumers through some of the largest financial institutions and most notable neo-banks and fintech companies in the world. The transaction, worth $275 million in cash and stock, was Cardlytics' first acquisition in its 13-year history. With the acquisition now closed, Dosh CEO and founder, Ryan Wuerch, will report to Lynne Laube. The two companies will continue to operate as separate advertising platforms in the near-term, with Dosh remaining in Austin, Texas and Cardlytics keeping its headquarters in Atlanta, Georgia.

ShowHide Related Items >><<
CDLX Cardlytics
$121.03 /

-6.56 (-5.14%)

CDLX Cardlytics
$121.03 /

-6.56 (-5.14%)

03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
CDLX Cardlytics
$121.03 /

-6.56 (-5.14%)

  • 03
    Mar
Upgrade
Cardlytics upgraded to Neutral from Underperform at BofA » 06:52
03/05/21
03/05
06:52
03/05/21
06:52
CDLX

Cardlytics

$126.31 /

+1.31 (+1.05%)

BofA analyst Nat…

BofA analyst Nat Schindler upgraded Cardlytics to Neutral from Underperform with a $128 price target. The company's $275M acquisition of the cash-back offers platform Dosh, which partners with neobanks and fintechs such as Venmo, Betterment and Ellevest, is complementary to its focus on large banks, the analyst tells investors in a research note.

ShowHide Related Items >><<
CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
01/14/21 William Blair
Cardlytics downgraded to Market Perform on valuation at William Blair
CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

  • 03
    Mar
Upgrade
Cardlytics upgraded to Neutral from Underperform at BofA » 06:10
03/05/21
03/05
06:10
03/05/21
06:10
CDLX

Cardlytics

$126.31 /

+1.31 (+1.05%)

BofA analyst Nat…

BofA analyst Nat Schindler upgraded Cardlytics to Neutral from Underperform with a $128 price target.

ShowHide Related Items >><<
CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
01/14/21 William Blair
Cardlytics downgraded to Market Perform on valuation at William Blair
01/14/21 William Blair
Cardlytics downgraded to Market Perform from Outperform at William Blair
CDLX Cardlytics
$126.31 /

+1.31 (+1.05%)

  • 03
    Mar
Syndicate
Cardlytics 3.85M share Secondary priced at $130.00 » 06:25
03/03/21
03/03
06:25
03/03/21
06:25
CDLX

Cardlytics

$134.04 /

-7.16 (-5.07%)

BofA, JPMorgan, Wells…

BofA, JPMorgan, Wells Fargo and Raymond James acted as joint book running managers for the offering.

ShowHide Related Items >><<
CDLX Cardlytics
$134.04 /

-7.16 (-5.07%)

CDLX Cardlytics
$134.04 /

-7.16 (-5.07%)

03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
01/14/21 William Blair
Cardlytics downgraded to Market Perform on valuation at William Blair
01/14/21 William Blair
Cardlytics downgraded to Market Perform from Outperform at William Blair
CDLX Cardlytics
$134.04 /

-7.16 (-5.07%)

  • 03
    Mar
Recommendations
Cardlytics price target raised to $150 from $90 at Truist » 08:26
03/02/21
03/02
08:26
03/02/21
08:26
CDLX

Cardlytics

$141.43 /

+8.88 (+6.70%)

Truist analyst Youssef…

Truist analyst Youssef Squali raised the firm's price target on Cardlytics to $150 from $90 and keeps a Buy rating on the shares. The company's Q4 results demonstrate that the COVID-19 recovery is tracking "slightly ahead" of estimates as demand saw a gradual sequential recovery across most verticals in the U.S., the analyst tells investors in a research note. Cardlytics' FY21 outlook was also better than consensus, but the slope of the recovery remains highly correlated to a recovery in consumer spending, Squali adds.

ShowHide Related Items >><<
CDLX Cardlytics
$141.43 /

+8.88 (+6.70%)

CDLX Cardlytics
$141.43 /

+8.88 (+6.70%)

03/01/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
01/14/21 William Blair
Cardlytics downgraded to Market Perform on valuation at William Blair
01/14/21 William Blair
Cardlytics downgraded to Market Perform from Outperform at William Blair
12/16/20 JPMorgan
Cardlytics price target raised to $110 from $82 at JPMorgan
CDLX Cardlytics
$141.43 /

+8.88 (+6.70%)

  • 03
    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.